Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021)

Nu-Med Plus (NUMD) posted Other Non Operating Income of $9384.0 for Q2 2021, up 100.14% sequentially from -$6.7 million in Q4 2017.

Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021) Analysis & Trends

Nu-Med Plus has reported Other Non Operating Income for 4 years, with the latest figure at $9384.0 in Q2 2021.

Quarterly Other Non Operating Income changed N/A year-over-year to $9384.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was $9384.0 (changed N/A YoY) and the FY2022 annual result came in at $50000.0, up 432.82% from the prior year.
Other Non Operating Income rose to $9384.0 in Q2 2021 per NUMD's latest filing, from -$6.7 million in the prior quarter.
Over five years, Other Non Operating Income peaked at $9384.0 in Q2 2021 and troughed at -$6.7 million in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.57 Bn	193.97 Bn	7.27 Bn
2	Stryker	129.62 Bn	126.15 Bn	4.50 Bn
3	Medtronic	119.89 Bn	110.67 Bn	6.41 Bn
4	Boston Scientific	74.01 Bn	73.47 Bn	3.85 Bn
5	Edwards Lifesciences	52.48 Bn	48.23 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.69 Bn	830.00 Mn
7	GE HealthCare Technologies	33.90 Bn	31.79 Bn	2.18 Bn
8	Koninklijke Philips	26.41 Bn	23.09 Bn	4.55 Bn
9	Steris	23.16 Bn	22.68 Bn	684.20 Mn
10	Nu-Med Plus	1.67 Mn	1.67 Mn	-

Download Data